Monoclonal Antibodies Market
According to Intent Market Research, the Monoclonal Antibodies Market is expected to grow from USD 92.5 Billion in 2024-e at a CAGR of 6.3% to touch USD 141.8 Billion by 2030. The Monoclonal Antibodies Market is dominated by key players such as, Roche, Merck & Co., Johnson & Johnson, AbbVie, Amgen, and Bristol-Myers Squibb.